SCIEX and Evosep Expand Access to Standardized Proteomics for Pharma and Biotech With New Reseller Agreement

SCIEX, and Evosep Biosystems, enter a reseller agreement to co-sell SCIEX mass spectrometry systems with the newly announced Evosep Eno, for standardized high-throughput proteomics. 

The reseller agreement empowers researchers to implement standardized proteomics workflows, delivering a robust LC-MS solution designed to meet the evolving demands of pharmaceutical and biotech companies. With Evosep Eno, researchers gain exceptional throughput, sensitivity, and reproducibility. When combined with SCIEX mass spectrometers—engineered for speed and sensitivity in both quantitative and qualitative analyses—this collaboration ensures access to cutting-edge technology tailored to today’s analytical challenges. 

The latest research from SCIEX and Evosep, shows that the Evosep Eno provides an >5-fold increase of peptide precursor identifications and an >3-fold increase of protein group identifications, at 500 SPD, when coupled to the new ZenoTOF 8600 system. This enables a greater depth of proteome coverage for large-scale cohort, high-throughput analysis. 

“Our collaboration with Evosep over the years has allowed us to continue to advance and standardize high throughput proteomics workflows. It is exciting to see the exceptional performance for the quantitative identification of peptides and proteins in complex samples, achieving throughputs up to 500 SPD. We are committed to provide the best solution for our customers,” said Jose Castro-Perez Ph.D., Vice President, Product Management at SCIEX. “ 

“For the application of proteomics in translational medicine, this extended collaboration between SCIEX and Evosep will further adoption of standardized solutions and make the technology more accessible—even to those new to proteomics,” said Morten Bern, CEO of Evosep. “Together, we have an exciting opportunity to make a meaningful impact through LC-MS–based proteomics by combining our strengths to deliver solutions that ultimately enhance patient care and improve quality of life.” 

This agreement allows users to access SCIEX mass spectrometry systems and the Evosep Eno via a single product catalogue issued by SCIEX. This option is available to customers located in the USA, Canada, Germany, France, Italy, Switzerland, Austria, Spain, Portugal, Sweden, Norway, Denmark, Finland, Belgium, Netherlands, Latvia, Lithuania, Estonia, and Luxembourg. Both vendors commit to deliver coordinated service and leading analytical performance. SCIEX will support the full customer relationship and Evosep will provide direct UHPLC service and support.